Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction

Chinese Medical Journal

Volumn 121, Issue 6, 2008, Pages 485-491

  Zhang, Qi ^a   Zhang, Rui Yan ^a   Qiu, Jian Ping ^b   Zhang, Jun Feng ^a   Wang, Xiao Long ^c   Jiang, Li ^d   Liao, Min Lei ^e   Zhang, Jian Sheng ^a   Hu, Jian ^a   Yang, Zheng Kun ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Cardiology   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d Shanghai Changning Center Hospital   (China)

^e Department of Cardiology   (China)

Author keywords

Acute myocardial infarction; Door to balloon time; Major adverse cardiac event; Percutaneous coronary intervention; Transfer

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; CHINA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT TRANSPORT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; SYMPTOM;

EID: 41649083195     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803020-00002     Document Type: Article

References (29)

1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-2098.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
3. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008; 117: 261-295.
4. Dudek D, Siudak Z, Kuta M, Dziewierz A, Mielecki W, Rakowski T, et al. Management of myocardial infaretion with ST-segment elevation in district hospitals without catheterisation laboratory - Acute Coronary Syndromes Registry of Malopolska 2002-2003. Kardiol Pol 2006; 64: 1053-1060.
5. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003; 108: 1809-1814.
6. Liem AL, van't Hof AW, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998; 32: 629-633.
7. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infaretion: a comprehensive review of contemporary management options. J Am Coll Cardiol 2007; 50: 917-929.
8. Nallamothu B, Fox KA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007; 93: 1552-1555.
9. Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ 2006; 175: 1527-1532.
10. Guerra DR, Gibson CM. Door-to-balloon delays with PCI in acute myocardial infarction. Curr Treat Options Cardiovase Med 2004; 6: 69-77.
11. Steg PG, Cambou JP, Goldstein P, Durand E, Sauval P, Kadri Z, et al. By passing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry. Heart 2006, 92: 1378-1383.
12. Zhang Q, Xu B, Yang YJ, Zhang RY, Li JP, Qiao SB, et al. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multicenter clinical study. Chin Med J 2007; 120: 533-538.
13. Zhang Q, Fang YH, Zhang RY, Hu J, Yang ZK, Ni J, et al. Drug-eluting stents improve clinical outcomes in Chinese diabetic patients with de novo coornary artery disease. Chin Med J 2006; 119: 1576-1579.
14. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kem MJ, King SB 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-e286.
15. Aytekin V. Update on ACC/ESC criteria for acute ST-elevation myocardial infarction. Anadolu Kardiyol Derg 2007; 7 Suppl 1: s14-s15.
16. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, et al. Early and long-term clinical outcomes associated with reinfaretion following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol 2003; 42: 7-16.
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-2351.
18. Cannon CP. Evolving management of ST-segment elevation myocardial infarction: update on recent data. Am J Cardiol 2006; 98(12A): 10Q-21Q.
19. Singh KP, Harrington RA. Primary percutaneous coronary intervention in acute myocardial infarction. Med Clin North Am 2007; 91: 639-655.
20. Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation 2006; 113: 1079-1085.
21. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-2947.
22. Widimsky P, Croch L, Zelizko M, Aschermann M, Behnar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823-831.
23. Grines CL, Westerhausen DR Jr, Grines LI, Hanlon JT, Logemann TL, Niemela M, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002, 39: 1713-1719.
24. Barbagelata A, Perna ER, Clemmensen P, Uresky BF, Canella JP, Califf RM, et al. Time to reperfusion in acute myocardial infarction. It is time to reduce it! J Electrocardiol 2007; 40: 257-264.
25. Dalby M, Montalescot G. Transfer for primary angioplasty: who and how? Heart 2002; 88: 570-572.
26. Vakili BA, Brown DL. Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health). Am J Cardiol 2003, 91: 726-728.
27. Brown DC, Mogelson S, Harris R, Kemp D, Massey M. Percutaneous coronary interventions in a rural hospital without surgical backup: report of one year of experience. Clin Cardiol 2006; 29: 337-340.
28. Antoniucci D. Glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous mechanical intervention for acute myocardial infarction. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 173-179.
29. Beeres SL, Oemrawsingh PV, Warda HM, Bechan R, Atsma DE, Jukema JW, et al. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty. Catheter Cardiovasc Interv 2005; 65: 478-483.